Nicholas Jason Singer Insider Profile
11 Followers
Nicholas Jason Singer, Director at Eterna Therapeutics, holds 388.04K shares in Eterna Therapeutics (Ticker: ERNA), holds 0.00 shares in Comera Life Sciences Holdings (Ticker: CMRA). Most recently, Nicholas Jason Singer Bought ― shares of Eterna Therapeutics on Dec 06, 2022 for an estimated value of $929.18K.
Nicholas Jason Singer's Trading History
You May Also Like
Nicholas Jason Singer insider profile FAQ
What stocks does Nicholas Jason Singer hold?
Nicholas Jason Singer holds: ERNA, CMRA stocks.
What was Nicholas Jason Singer’s latest transaction?
Nicholas Jason Singer’s latest transaction was an Informative Buy of $929.18K.
What is Nicholas Jason Singer's role in Eterna Therapeutics?
Nicholas Jason Singer's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
